Skip to main content

Aeterna Zentaris Inc(AEZS-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Aeterna Zentaris Inc flat on Monday (AEZS)

AI-generated - The Globe and Mail - Mon Jan 22, 3:01PM CST

Today, shares of Aeterna Zentaris Inc opened at $2.63 and closed at $None. Intraday prices ranged from a low of $2.63 to a high of $2.63.

Share prices $verbed percentage_change% from the previous day's close of $2.63.

During the day across North America, the TSX Composite closed 0.72% at 20906.52, the S&P 500 closed 1.23% at 4839.81, the Dow Jones Industrial Average closed 1.05% at 37863.80 and the Nasdaq Composite closed 1.70% at 15310.97.

Aeterna Zentaris Inc traded under AEZS on the Toronto Stock Exchange (TSX).

A total of 508 shares was traded during the session, with total trades of 5. On average, Aeterna Zentaris Inc has traded 705 shares in the last five days and 974 year-to-date.

The TSX overall saw 3,660 price advancers against 1,573 declines and 108 unchanged.

During the prior 52 weeks, AEZS.TO has traded as high as $5.18 (January 31,2023) and low as $1.91 (November 01,2023). Moreover, in the last 12 months, Aeterna Zentaris Inc's shares have shrunken -48.33%, while they have advanced 2.33% year-to-date.

It announced a 1237.50 dividend on July 22/99, with an August 11/99 ex-date and January 01/70 pay day.

Following today's trading, Aeterna Zentaris Inc has a market capitalization of $12.77 million on a float of 4,856 shares outstanding. Its annual EPS is $-4.81.

Aeterna Zentaris Inc is a TSX Biotechnology company headquartered in Toronto, CAN.

Aeterna Zentaris Inc's average recommendation is "Strong Buy" based on 1.00 analysts according to Zacks. From those 1 analysts, 1 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe